Plus Therapeutics, Inc. (PSTV) — 分析师展望 / 分析师共识目标价为. 基于 4 位分析师评级, 共识为 看涨 — 3 买入, 1 持有.
分析师共识目标价为 $1.00, 下跌空间为 82.3% 相对于当前价格 $5.65.
分析师预估 每股收益(EPS)为 $-1.87 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.95 vs 预期 $-1.87 (不及预期 -4.8%). 2025: 实际 $-0.29 vs 预期 $-0.24 (不及预期 -19.8%). 分析师准确度: 89%.
PSTV 股票 — 12个月价格预测
$1.00
▼ -82.30% 下跌空间
平均目标价
Based on 4 Wall Street analysts offering 12-month price targets for Plus Therapeutics, Inc., the price target is $1.00.
平均目标价相对最新价格 $5.65 变动 -82.30%。
PSTV 分析师评级
Buy
基于过去3个月内 4 位分析师对 Plus Therapeutics, Inc. 的评级
EPS 预测 — PSTV
89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.95
vs Est –$1.87
▼ 4.6% off
2025
Actual –$0.29
vs Est –$0.24
▼ 16.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — PSTV
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.006B
vs Est $0.006B
▲ 5.1% off
2025
Actual $0.005B
vs Est $0.005B
▲ 0.3% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
